Skip to main content

Glaxosmithkline Consumer Healthcare Holdings Recall: Fiber prebiotic product potentially contaminated with small plastic pieces

United States

TerminatedClass II

Company
Glaxosmithkline Consumer Healthcare Holdings
Product
Benefiber Healthy Shape Prebiotic Fiber Supplement, 500G UP…
Recall date
April 28, 2020
Terminated
June 1, 2021
Source
FDA

Reason for recall

Fiber prebiotic product potentially contaminated with small plastic pieces

  1. - Recall initiated
  2. - Reported by source
  3. - Recall terminated
Recalled products
Product description UPC Quantity Lot / code information
Benefiber Healthy Shape Prebiotic Fiber Supplement, 500G UPC 886790018872 886790018872 29,844 bottles Lot: MP8B (EXP Sep2021)

Distribution

  • Distributed to the following US states: AR
  • CA
  • FL
  • HI
  • ID
  • IL
  • LA
  • MA
  • ME
  • MI
  • MN
  • MO
  • NC
  • NE
  • NJ
  • NY
  • OH
  • OR
  • PA
  • RI
  • SC
  • TX
  • VA
  • WA
  • and WI

Official source record

Agency
FDA
Dataset
FDA Food Enforcement (Recalls)
Recall number
F-0950-2020
Event ID
85554
Status
Terminated
Classification
Class II
Company
Glaxosmithkline Consumer Healthcare Holdings
Product description
Benefiber Healthy Shape Prebiotic Fiber Supplement, 500G UPC 886790018872
Quantity
29,844 bottles
Reason
Fiber prebiotic product potentially contaminated with small plastic pieces
Recall initiation date
April 28, 2020
Report date
May 13, 2020
Classification date
Not published in this source record
Termination date
June 1, 2021
Distribution pattern
Distributed to the following US states: AR, CA, FL, HI, ID, IL, LA, MA, ME, MI, MN, MO, NC, NE, NJ, NY, OH, OR, PA, RI, SC, TX, VA, WA, and WI
UPC, lot, and code information
UPC 886790018872; Lot: MP8B (EXP Sep2021)
Voluntary or mandated
Voluntary: Firm initiated
Initial notification method
Press Release
Source last updated
Not tracked separately from the Public Health Trace retrieval date below
Public Health Trace retrieval date

Other products recalled under this same event

This recall shares FDA event ID 85554 with 1 other product entry in Public Health Trace.

FDA Recall United States Terminated Historical recordClass II

Glaxosmithkline Consumer Healthcare Holdings

Product
Benefiber Prebiotic Fiber Supplement, packaged in the follow…
Published
May 13, 2020
Distribution
Distributed to the following US states:…

View recall →

Responsible company: Glaxosmithkline Consumer Healthcare Holdings

Other recalls from Glaxosmithkline Consumer Healthcare Holdings

FDA Recall Terminated Historical recordClass II

Childrens Dimetapp Cold & Cough, For ages 6 yrs. & over, 8 FL OZ. bottle, (237 mL), Distributed by: Pfizer Madison, NJ 07940, Made in Canada, UPC: 60300312234196, NDC: 0031-2234-19.

by Glaxosmithkline Consumer Healthcare Holdings

Published
July 8, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Childrens Robitussin Honey Cough and Chest Congestion DM, dextromethorphan (cough suppressant), guaifenesin (expectorant), 4 FL OZ. bottle (118 mL), Distributed by: Pfizer, Madison, NJ 07940 USA, UPC: 50300318760128, NDC: 0031-8760-12.

by Glaxosmithkline Consumer Healthcare Holdings

Published
July 8, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Gaviscon Liquid Antacid Extra Strength, Cool Mint, 12 FL OZ (355 mL) single pack and twin pack, Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0095-41

by Glaxosmithkline Consumer Healthcare Holdings

Published
June 24, 2020
Distribution
Nationwide

View recall →

Distribution map

A map highlighting the states named in the source's distribution description.

Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.

Distribution map
State Distributed
Arkansas 1
California 1
Florida 1
Hawaii 1
Idaho 1
Illinois 1
Louisiana 1
Massachusetts 1
Maine 1
Michigan 1
Minnesota 1
Missouri 1
North Carolina 1
Nebraska 1
New Jersey 1
New York 1
Ohio 1
Oregon 1
Pennsylvania 1
Rhode Island 1
South Carolina 1
Texas 1
Virginia 1
Washington 1
Wisconsin 1

States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.

Where this information comes from

View FDA enforcement record -- the specific openFDA record this summary was built from.

No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Technical source data

View raw source data -- the machine-readable record this page's information was built from.

Retrieved by Public Health Trace:

Frequently asked questions

What does a Class II mean?

A situation in which use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote.

Is this recall still active?

According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this product?

Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.

Where can I find more official information?

The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.